PRTK
Price:
$2.23
Market Cap:
$127.83M
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co....[Read more]
Industry
Biotechnology
IPO Date
2009-02-03
Stock Exchange
NASDAQ
Ticker
PRTK
According to Paratek Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 22.36%. This represents a change of 139.98% compared to the average of 9.32% of the last 4 quarters.
The mean historical ROE of Paratek Pharmaceuticals, Inc. over the last ten years is -10.49%. The current 22.36% ROE has changed -313.20% with respect to the historical average. Over the past ten years (40 quarters), PRTK's ROE was at its highest in in the June 2019 quarter at 242.75%. The ROE was at its lowest in in the March 2019 quarter at -222.13%.
Average
-10.49%
Median
-28.49%
Minimum
-235.52%
Maximum
324.24%
Discovering the peaks and valleys of Paratek Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 273.70%
Maximum Annual ROE = 324.24%
Minimum Annual Increase = -237.67%
Minimum Annual ROE = -235.52%
Year | ROE | Change |
---|---|---|
2022 | 37.16% | -19.62% |
2021 | 46.24% | -59.33% |
2020 | 113.69% | -64.94% |
2019 | 324.24% | -237.67% |
2018 | -235.52% | 118.51% |
2017 | -107.78% | -30.88% |
2016 | -155.93% | 122.79% |
2015 | -69.99% | 273.70% |
2014 | -18.73% | -51.04% |
2013 | -38.26% | 203.71% |
The current ROE of Paratek Pharmaceuticals, Inc. (PRTK) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
65.70%
5-year avg
57.16%
10-year avg
-10.49%
Paratek Pharmaceuticals, Inc.’s ROE is less than Selecta Biosciences, Inc. (67.13%), greater than Corvus Pharmaceuticals, Inc. (-53.99%), greater than Immutep Limited (-42.11%), greater than Icosavax, Inc. (-41.24%), less than Lyra Therapeutics, Inc. (0%), greater than Equillium, Inc. (-143.74%), greater than HOOKIPA Pharma Inc. (-36.88%), greater than LianBio (-51.77%), greater than Jasper Therapeutics, Inc. (-38.06%), greater than Affimed N.V. (-64.68%), greater than Leap Therapeutics, Inc. (-155.57%), greater than Adaptimmune Therapeutics plc (-98.01%), greater than Aptose Biosciences Inc. (-117.47%), greater than null (-5693.38%),
Company | ROE | Market cap |
---|---|---|
67.13% | $135.20M | |
-53.99% | $252.08M | |
-42.11% | $382.21M | |
-41.24% | $769.04M | |
0% | $17.85M | |
-143.74% | $32.80M | |
-36.88% | $159.50M | |
-51.77% | $34.47M | |
-38.06% | $281.41M | |
-64.68% | $57.26M | |
-155.57% | $107.52M | |
-98.01% | $278.72M | |
-117.47% | $6.57M | |
-5693.38% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Paratek Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Paratek Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Paratek Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Paratek Pharmaceuticals, Inc. (PRTK)?
What is the highest ROE for Paratek Pharmaceuticals, Inc. (PRTK)?
What is the 3-year average ROE for Paratek Pharmaceuticals, Inc. (PRTK)?
What is the 5-year average ROE for Paratek Pharmaceuticals, Inc. (PRTK)?
How does the current ROE for Paratek Pharmaceuticals, Inc. (PRTK) compare to its historical average?